CIVIL SOCIETY FORUM ON DRUGS
The Civil Society Forum on Drugs (CSFD) is an expert group to the European Commission. Its membership comprises 45 civil society organisations coming from across Europe and representing a variety of fields of drug policy, and a variety of stances within those fields. Its purpose is to provide a broad platform for a structured dialogue between the Commission and the European civil society which supports drug policy formulation and implementation through practical advice. The momentum for the CSFD’s formation can be traced back to the Green Paper on the Role of Civil Society in Drugs Policy in the European Union (EU Green Paper Reference).
Overall, the CSFD is governed by a core group, comprising the four Chairs of the working groups, along with a Chair and Vice-Chair of the forum itself, again elected by the members of the forum at the plenary.
NEWS
Check the latest CSFD Newsletter
In order to read the latest CSFD updates, news and activities, please click here.
Contributions from the Civil Society Forum on Drugs to the EU-Russia bilateral dialogue on drugs (November, 2020)
This paper by the EU Civil Society Forum on Drugs (CSFD) aims to contribute to the bilateral dialogue between the EU and Russia planned for 24th November 2020, highlighting key issues of concern to feed into the discussion. This contribution follows previous papers produced at the occasion of...
Assessment Report & Literature Review – meaningful civil society involvement in the area of drug policy in Europe
This report reflects the wealth of information on definitions and forms of civil society, on levels of involvement, best practices and lessons learnt. Furthermore, the report identifies gaps in information and knowledge and provides recommendations for future action. Please read the full report...
CSFD POSITION PAPER(1) – The WHO recommendations on the rescheduling of cannabis and cannabis-related substances
In 2018, the WHO’s Expert Committee on Drug Dependence presented the results of the first-ever review of cannabis and cannabis-related substances, which was undertaken at the formal request of the UN Commission on Narcotic Drugs (CND).13 The review resulted in the six recommendations that will be...
Contribution from the Civil Society Forum on Drugs to the 3rd intersessional meeting of the 63rd session of the Commission on Narcotic Drugs – 19 to 21 October 2020
The Civil Society Forum on Drugs in the EU (the ‘CSFD’) welcomes the opportunity to contribute with this submission to the forthcoming 3rd intersessional meeting of the 63rd session of the Commission on Narcotic Drugs (‘CND’), which will take place from 19 to 21 October 2020. Topics: New...
Civil Society Forum on Drugs’ response on the EU Drug Agenda 2020-2025
The European Commission has recently published the communication on the EU Drugs Agenda and Action Plan (2021-2025), a proposal for setting out the political framework, priorities and actions for implementing EU drugs policy over the next 5 years. The CSFD, as an expert group of the European...
Statement of the EU Civil Society Forum on Drugs on vulnerable groups in the field of drug demand reduction
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Drug Report 2020 estimates that around 96 million or 29 % of adults (aged 15-64) in the European Union are estimated to have used illicit drugs at least once in their lifetime. Although, most people who use drugs are using them...
NLO Week
Today is the first day of the NLO Week - check the program here
Check it Out – the latest CSFD Newsletter
Please click here to read the latest updates from the CSFD including and update from the chair Laurene Collard, chairs of the working groups and CSFD project.